These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3973063)
1. Studies with stable isotopes I: Changes in phenytoin pharmacokinetics and biotransformation during monotherapy. Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ; Schumacher GE J Clin Pharmacol; 1985; 25(1):43-50. PubMed ID: 3973063 [TBL] [Abstract][Full Text] [Related]
2. Studies with stable isotopes III: Pharmacokinetics of tracer doses of drug. Browne TR; Greenblatt DJ; Harmatz JS; Evans JE; Szabo GK; Evans BA; Schumacher GE J Clin Pharmacol; 1985; 25(1):59-63. PubMed ID: 3973065 [TBL] [Abstract][Full Text] [Related]
3. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio. Bourgeois BF; Wad N Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240 [TBL] [Abstract][Full Text] [Related]
4. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth. Kamali F; Ball DE; McLaughlin WS; Seymour RA J Periodontal Res; 1999 Apr; 34(3):145-53. PubMed ID: 10384402 [TBL] [Abstract][Full Text] [Related]
5. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate. Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826 [TBL] [Abstract][Full Text] [Related]
6. The elimination of phenytoin in man. Eadie MJ; Tyrer JH; Bochner F; Hooper WD Clin Exp Pharmacol Physiol; 1976; 3(3):217-24. PubMed ID: 975617 [TBL] [Abstract][Full Text] [Related]
7. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy. Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690 [TBL] [Abstract][Full Text] [Related]
8. Kinetic equivalence of stable-isotope-labeled and unlabeled phenytoin. Browne TR; Van Langenhove A; Costello CE; Biemann K; Greenblatt DJ Clin Pharmacol Ther; 1981 Apr; 29(4):511-5. PubMed ID: 7471618 [TBL] [Abstract][Full Text] [Related]
9. Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics. Browne TR; Szabo GK; Evans J; Evans BA; Greenblatt DJ; Mikati MA Neurology; 1988 Apr; 38(4):639-42. PubMed ID: 3352926 [TBL] [Abstract][Full Text] [Related]
10. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man. Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326 [TBL] [Abstract][Full Text] [Related]
11. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man. Maguire JH; Kraus BL; Butler TC; Dudley KH Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability studies of drugs with nonlinear pharmacokinetics: II. Absolute bioavailability of intravenous phenytoin prodrug at therapeutic phenytoin serum concentrations determined by double-stable isotope technique. Browne TR; Szabo GK; McEntegart C; Evans JE; Evans BA; Miceli JJ; Quon C; Dougherty CL; Kres J; Davoudi H J Clin Pharmacol; 1993 Jan; 33(1):89-94. PubMed ID: 8429121 [TBL] [Abstract][Full Text] [Related]
13. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Mamiya K; Ieiri I; Shimamoto J; Yukawa E; Imai J; Ninomiya H; Yamada H; Otsubo K; Higuchi S; Tashiro N Epilepsia; 1998 Dec; 39(12):1317-23. PubMed ID: 9860067 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependence of the apparent half-life of phenytoin in the rat. Vicuna A; Lalka D; duSouich P; Vicuna N; Ludden TM; McLean AJ Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):3-11. PubMed ID: 7394315 [TBL] [Abstract][Full Text] [Related]
15. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients. Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670 [TBL] [Abstract][Full Text] [Related]